Anzeige
Mehr »
Login
Samstag, 13.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Spezial: Montag letzte Chance vor großer Verkündung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Business Review

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
08.03.iOnctura receives orphan drug status for pancreatic cancer therapy
07.03.Sionna Therapeutics secures $182m for cystic fibrosis drug development
06.03.UK NICE recommends GSK's Dostarlimab regimen for womb cancer
05.03.FDA approves Formosa-AimMax's post-surgery eye care treatment
04.03.EMA validates Daiichi Sankyo-AstraZeneca's cancer therapy applications
01.03.Kenai secures funds for neurological cell therapy development
29.02.SN Bioscience's SNB-101 received FDA orphan drug designation
28.02.Merck KGaA to open new distribution centre in Brazil for Life Science sector
27.02.Baseimmune secures funding for vaccine development
26.02.EMA CHMP provides positive opinion for Janssen's multiple myeloma therapy
23.02.FDA grants fast track status to Artiva's AlloNK for lupus nephritis
22.02.FDA accepts Servier's NDA review for glioma treatment
21.02.IsomAb secures funds to advance peripheral arterial disease treatment
20.02.Everest Medicines to terminate deal with Providence for mRNA platform
19.02.FDA grants breakthrough therapy status for Otsuka's IgAN drug
16.02.Japan grants priority review for Astellas' urothelial cancer regimen
15.02.Atara submits IND application to FDA for CAR T-cell therapy
14.02.ProfoundBio secures $112m to advance ADC portfolio for cancer
13.02.Precision receives payments from TG Therapeutics for azer-cel
12.02.FDA grants orphan drug designation for Disc's PV treatment
09.02.Aizon secures funds to accelerate development pipeline
08.02.Samsung Biologics and LegoChem enter ADC development deal
07.02.NIH grants $9m for nicotine cessation drug development
06.02.Exicure and Bluejay sign hepatitis treatment development deal
05.02.Zuellig Pharma acquires Cialis and Alimta brands from Lilly